Shortages of flu shots this year are not related to drugmakers ramping up production of potential Covid-19 vaccines, the head of vaccines at GlaxoSmithKline (GSK) said.
Amgen and AstraZeneca announced that their Phase III NAVIGATOR trial of the potential first-in-class human monoclonal antibody tezepelumab hit the primary endpoint in severe asthma.
U.S. Health Secretary Alex Azar said if pharmaceutical company Pfizer Inc. submits interim Covid-19 vaccine to health regulators as quickly as expected, the U.S. government anticipates the beginning of vaccinating Americans in December.
U.S. allows emergency use of first Covid-19 antibody drug
Adults 65 and Older, Business, Clinical Trials, COVID-19 antibody drugs, Dr. Anthony Fauci (Director), Emergency Use Authorization, FDA, Hospitalized COVID-19 Patients, Monoclonal Antibodies, R&D, Regeneron Pharmaceuticals, Shares, White HouseU.S. regulators authorized emergency use of the first experimental antibody drug for Covid-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
Novavax Inc. is on track to begin a delayed U.S.-based, late-stage study of the company’s experimental coronavirus vaccine during November
‘Great day for humanity’: Pfizer says Covid-19 vaccine over 90% effective
Analysis, BioNTech, Business, Clinical Trials, CNBC, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Vaccines, Donald Trump, Efficacy, Health Experts, Joe Biden, Messenger RNA (mRNA) Vaccines, Moderna, Pfizer, R&D, Stock Markets, U.S. governmentPfizer Inc.’s experimental Covid-19 vaccine was more than 90% effective based on initial trial results, the company said, a major victory in the fight against a pandemic that has killed more than 1 million people and battered the world’s economy.
Shares of Calliditas Therapeutics soared in trading after the company announced positive Phase III data from a study of Nefecon in IgA nephropatjhy (IgAN), an autoimmune renal disease.
An AstraZeneca executive said he felt encouraged by “incredibly promising” large-scale Covid-19 vaccine trial results unveiled by New York-based Pfizer and the company’s German partner BioNTech.
ViiV’s Cabotegravir Beats Out Gilead’s Truvada for Preventing HIV in Women
Blockbusters, Clinical Data, Clinical Trials, HIV Prevention, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health, R&D, Shareholders, The Bill and Melinda Gates Foundation, Therapeutics, WomenViiV Healthcare announced that an independent data safety monitoring board (DSMB) recommended the early unblinding of data from the HIV Prevention Trials Network 084 trial of the investigational, long-acting injectable cabotegravir for HIV prevention in women.
The Coalition for Healthcare Communication will present a special post-election webinar on Nov. 19 featuring Kate Rawson – senior editor of Prevision Policy and an experienced, well-connected inside-the-beltway observer – with a more in-depth look at implications of the 2020 elections for healthcare policy.